Clinical Trial Update: Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy results for Thykamine in mild-to-moderate atopic dermatitis (eczema).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Thykamine

Snippet

Sponsor: PurGenesis Technologies Inc. | Conditions: Atopic Dermatitis Eczema | Phase 2 | Status: COMPLETED